可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Blum A, Miller H. Pathophysiological role of cytokines in congestive heart failure[J]. Annu Rev Med, 2001, 52: 15-27.
[2] Li YY, Feng YQ, Kadokami T, et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by antitumor necrosis factor alpha therapy[J]. Proc Natl Acad Sci USA, 2000, 97: 12746-1275I.
[3] 臧益民,臧伟进,王晓明.心力衰竭的病理生理机制及治疗概述[J]. 心脏杂志,2002,14(5):417-419.
[4] Coletta AP, Clark AL, Banarjee P, et al. Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH[J]. Eur J Heart Fail, 2002, 4(4): 559-561.
[5] 王晓明,李源,李慧,等.心力衰竭患者血清中TNFα、IL1及IL6的变化及培哚普利对其影响[J]. 心脏杂志,2002,14(4):318-322.
[6] Damas JK, Lars G, Aass H, et al. Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure modulatory effects of intravenous immunoglobulin[J]. J Am Coll Cardiol, 2001, 38(1): 187-193.
[7] Damas JK, Eiken HG, Qie E, et al. Myocardial expression of CC CXCchemokines and their receptors in human endstage heart failure[J]. Cardiovasc Res, 2000, 47: 778-787.
[8] Pan G, Ni J, Wei YF , et al. An antagonist decoy receptor and a death domaincontaining receptor for TRAIL[J]. Science, 1997, 277: 815-818.
[9] Kang PM, Izumo S. Apoptosis and heart failure:a critical review of the literature[J]. Cir Res, 2000, 86: 1107-1113.
[10]Nelson DP, Setser E, Hall DG, et al. Proinflammatory consequences of transgenic fas ligand expression in the heart[J]. J Clin Invest, 2000, 105: l 199-1208.